Change history
30 November 2018
In the version of this article initially published, Table 1 listed SM04554 as a Wnt pathway inhibitor; in fact, it is a Wnt pathway activator. The error has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheridan, C. Wnt is back in drugmakers' sights, but is it druggable?. Nat Biotechnol 36, 1028–1029 (2018). https://doi.org/10.1038/nbt1118-1028
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1118-1028
- Springer Nature America, Inc.
This article is cited by
-
The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway
Journal of Experimental & Clinical Cancer Research (2022)